Prima BioMed, Ltd. PBMD
PBMD stood out among yesterday’s fresh news plays with a solid performance on the day. It was helped along by the announcement that the European Medicines Agency had given positive Scientific Advice with regard to the development path for its metastatic breast cancer treatment.
We observed as the stock traded in a daily range from 1.42 to 1.78, representing a respectable 25% intraday swing, and it did so on the strength of nearly 3.5X its 3-month average volume.
Looking at some of the still-bullish features PBMD chart, we’re going to stay open to the possibility of seeing further upswings in the near future:
- Prima BioMed Receives Positive Scientific Advice From the European Medicines Agency for Its Lead Product, IMP321 (Tue, Jul 7)
American Green, Inc. ERBB
We highlighted ERBB on Friday as a potential bottom-watch candidate, and the stock has responded with a nice move so far this week. It was trading at a low of .0039 to start things off on Monday, and yesterday we watched as it reached a .0049 high; a two-day swing of 26%
The company just completed an important step in their current business plan which was reported in a PR yesterday (link below). It was in reference to the partnership ERBB has formed to construct a legal marijuana grow operation in Colorado, which will purportedly focus solely upon the propagation of “CBD-rich cannabis strains”. It’s a story we’ll continue to follow as more details become available.
Ascent Solar Technologies, Inc. ASTI
We’re also still on alert with regard to an inclusion in Monday’s premarket report; ASTI has been making its way toward a bottom for the past few months. Yesterday we observed a low .451 toward the end of the session, and it appears that will be marked down as the the rebound point as the stock is gapping up heavily in early trading today with the help of a very positive PR.
As of this morning’s premarket high of .80 we’ve already seen a 77% swing in less than 24 hours. We’ll keep a close watch on ASTI today as this morning’s news of its 233% quarter-over-quarter revenue increase filters down and reaches more sets of eyes.
- Ascent Solar Announces Preliminary Q2-2015 Revenue of $2.2M, Approximately 233% Growth over Q1-2015 (Wed 6:00AM EDT)
Extended Watchlist:
BTU, IPDN, UWTI, OCLS, GBSN, AMDA, CNXS(>Interesting PR)